Masato Nakamura

6PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRespiratory diseasesNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 18, 2026
Durable Disease Control With Atezolizumab Plus Bevacizumab but Limited Post-Progression Outcomes: A Multicenter Real-World Study in Advanced Hepatocellular Carcinoma.

Masanori Inoue, Sadahisa Ogasawara, Kazuhisa Asahara

|Feb 27, 2025
Durvalumab Monotherapy in Complex Advanced Hepatocellular Carcinoma: A Real-World Study of Patients Ineligible for Combination Immunotherapy.

Chihiro Miwa, Sadahisa Ogasawara, Takuya Yonemoto

|Sep 09, 2024
Dual effects of targeting neuropilin-1 in lenvatinib-resistant hepatocellular carcinoma: inhibition of tumor growth and angiogenesis.

Junjie Ao, Na Qiang, Hiroaki Kanzaki

|Oct 05, 2023
A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study.

Kazufumi Kobayashi, Sadahisa Ogasawara, Susumu Maruta

|Oct 14, 2022
Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus.

Yaojia Ma, Shingo Nakamoto, Junjie Ao

|Jun 01, 2022
A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosis.

Takafumi Sakuma, Masato Nakamura, Tetsuhiro Chiba

Pageof 1

Frequent Collaborators

4 joint publications

Sadahisa Ogasawara

2 joint publications

Junjie Ao

2 joint publications

Naoya Kanogawa

2 joint publications

Masanori Inoue